Valeria Merz

1.4k total citations
36 papers, 851 citations indexed

About

Valeria Merz is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Valeria Merz has authored 36 papers receiving a total of 851 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 13 papers in Surgery and 13 papers in Molecular Biology. Recurrent topics in Valeria Merz's work include Pancreatic and Hepatic Oncology Research (18 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers) and Gastric Cancer Management and Outcomes (6 papers). Valeria Merz is often cited by papers focused on Pancreatic and Hepatic Oncology Research (18 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers) and Gastric Cancer Management and Outcomes (6 papers). Valeria Merz collaborates with scholars based in Italy, United Kingdom and Spain. Valeria Merz's co-authors include Davide Melisi, Camilla Zecchetto, Raffaela Santoro, Francesca Simionato, Geny Piro, Giampaolo Tortora, Carmine Carbone, Aldo Scarpa, Marco Zanotto and Carlo Messina and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Valeria Merz

33 papers receiving 847 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Valeria Merz Italy 16 445 353 186 179 159 36 851
Francesca Simionato Italy 17 455 1.0× 290 0.8× 199 1.1× 199 1.1× 125 0.8× 31 794
Camilla Zecchetto Italy 12 417 0.9× 376 1.1× 196 1.1× 138 0.8× 254 1.6× 28 856
Guido Giordano Italy 16 493 1.1× 267 0.8× 225 1.2× 179 1.0× 104 0.7× 76 916
Lydie Crescence France 16 492 1.1× 378 1.1× 199 1.1× 145 0.8× 105 0.7× 31 1.1k
Markus W. Buechler Germany 14 422 0.9× 284 0.8× 110 0.6× 282 1.6× 181 1.1× 30 841
Cinzia Puppin Italy 23 369 0.8× 782 2.2× 220 1.2× 103 0.6× 99 0.6× 46 1.2k
Brett H. Herzog United States 12 631 1.4× 333 0.9× 112 0.6× 116 0.6× 130 0.8× 17 1.1k
Behrouz Zand United States 12 350 0.8× 364 1.0× 143 0.8× 86 0.5× 64 0.4× 34 869
Moubin Lin China 16 413 0.9× 333 0.9× 218 1.2× 145 0.8× 288 1.8× 54 978
Sylvia Timme Germany 17 388 0.9× 369 1.0× 179 1.0× 133 0.7× 234 1.5× 37 795

Countries citing papers authored by Valeria Merz

Since Specialization
Citations

This map shows the geographic impact of Valeria Merz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Valeria Merz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Valeria Merz more than expected).

Fields of papers citing papers by Valeria Merz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Valeria Merz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Valeria Merz. The network helps show where Valeria Merz may publish in the future.

Co-authorship network of co-authors of Valeria Merz

This figure shows the co-authorship network connecting the top 25 collaborators of Valeria Merz. A scholar is included among the top collaborators of Valeria Merz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Valeria Merz. Valeria Merz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pietrobono, Silvia, et al.. (2024). CCL3 predicts exceptional response to TGFβ inhibition in basal-like pancreatic cancer enriched in LIF-producing macrophages. npj Precision Oncology. 8(1). 246–246. 4 indexed citations
2.
Pietrobono, Silvia, Federica Fazzini, Valeria Merz, et al.. (2023). Autotaxin Secretion Is a Stromal Mechanism of Adaptive Resistance to TGFβ Inhibition in Pancreatic Ductal Adenocarcinoma. Cancer Research. 84(1). 118–132. 15 indexed citations
3.
Zecchetto, Camilla, Valeria Merz, Silvia Pietrobono, et al.. (2023). Targeting FGFR Pathway Is Not an Effective Therapeutic Strategy in Patients with Unselected Metastatic Esophagogastric Cancer Resistant to Trastuzumab. Journal of Personalized Medicine. 13(3). 508–508. 1 indexed citations
4.
Bencivenga, Maria, Lorena Torroni, Camilla Zecchetto, et al.. (2023). YAP Activation Is Associated with a Worse Prognosis of Poorly Cohesive Gastric Cancer. Journal of Personalized Medicine. 13(9). 1294–1294. 1 indexed citations
5.
Merz, Valeria, Carlo Messina, Camilla Zecchetto, et al.. (2023). Is There Room for Liposomal Irinotecan in Biliary Tract Cancer? A Meta-analysis of Randomised Trials. Clinical Oncology. 36(2). 87–97. 2 indexed citations
6.
Merz, Valeria, Camilla Zecchetto, Silvia Pietrobono, et al.. (2022). Predictive Biomarkers for a Personalized Approach in Resectable Pancreatic Cancer. Frontiers in Surgery. 9. 866173–866173. 5 indexed citations
7.
Rizzo, Alessandro, Massimiliano Salati, Giorgio Frega, et al.. (2021). Second-line chemotherapy (2L) in elderly patients with advanced biliary tract cancer (ABC): A multicenter real-world study.. Journal of Clinical Oncology. 39(3_suppl). 322–322. 3 indexed citations
8.
Merz, Valeria, Camilla Zecchetto, Alessandro Cavaliere, et al.. (2021). Targeting KRAS: The Elephant in the Room of Epithelial Cancers. Frontiers in Oncology. 11. 638360–638360. 44 indexed citations
9.
Melisi, Davide, Do‐Youn Oh, Antoine Hollebecque, et al.. (2021). Safety and activity of the TGFβ receptor I kinase inhibitor galunisertib plus the anti-PD-L1 antibody durvalumab in metastatic pancreatic cancer. Journal for ImmunoTherapy of Cancer. 9(3). e002068–e002068. 149 indexed citations
10.
Merz, Valeria, Camilla Zecchetto, Raffaela Santoro, et al.. (2020). Plasma IL8 Is a Biomarker for TAK1 Activation and Predicts Resistance to Nanoliposomal Irinotecan in Patients with Gemcitabine-Refractory Pancreatic Cancer. Clinical Cancer Research. 26(17). 4661–4669. 19 indexed citations
11.
Gelsomino, Fabio, Andrea Spallanzani, Simone Benatti, et al.. (2020). 63P Multicentre match-paired analysis of advanced biliary cancer (ABC) long-term survivors: The BILONG study. Annals of Oncology. 31. S265–S265. 1 indexed citations
12.
Santoro, Raffaela, Marco Zanotto, Francesca Simionato, et al.. (2019). Modulating TAK1 Expression Inhibits YAP and TAZ Oncogenic Functions in Pancreatic Cancer. Molecular Cancer Therapeutics. 19(1). 247–257. 47 indexed citations
13.
Gueorguieva, Ivelina, Josep Tabernero, Davide Melisi, et al.. (2019). Population pharmacokinetics and exposure–overall survival analysis of the transforming growth factor-β inhibitor galunisertib in patients with pancreatic cancer. Cancer Chemotherapy and Pharmacology. 84(5). 1003–1015. 18 indexed citations
14.
Messina, Carlo, Valeria Merz, M. Frisinghelli, et al.. (2019). Adjuvant chemotherapy in resected bile duct cancer: A systematic review and meta-analysis of randomized trials. Critical Reviews in Oncology/Hematology. 143. 124–129. 20 indexed citations
15.
Carbone, Carmine, Geny Piro, Valeria Merz, et al.. (2018). Angiopoietin-Like Proteins in Angiogenesis, Inflammation and Cancer. International Journal of Molecular Sciences. 19(2). 431–431. 161 indexed citations
16.
Carbone, Carmine, Geny Piro, Francesca Simionato, et al.. (2017). Homeobox B9 Mediates Resistance to Anti-VEGF Therapy in Colorectal Cancer Patients. Clinical Cancer Research. 23(15). 4312–4322. 41 indexed citations
17.
Melisi, Davide, Geny Piro, Francesca Simionato, et al.. (2017). A circulating TH2 cytokines profile predicts survival in patients with resectable pancreatic adenocarcinoma. Annals of Oncology. 28. v27–v27.
18.
Carbone, Carmine, Geny Piro, Francesca Ligorio, et al.. (2017). Adipocytes sustain pancreatic cancer progression through a non-canonical WNT paracrine network inducing ROR2 nuclear shuttling. International Journal of Obesity. 42(3). 334–343. 35 indexed citations
19.
Piro, Geny, Carmine Carbone, Ivana Cataldo, et al.. (2016). An FGFR3 Autocrine Loop Sustains Acquired Resistance to Trastuzumab in Gastric Cancer Patients. Clinical Cancer Research. 22(24). 6164–6175. 68 indexed citations
20.
Piro, Geny, Simone Giacopuzzi, Maria Bencivenga, et al.. (2015). TAK1-regulated expression of BIRC3 predicts resistance to preoperative chemoradiotherapy in oesophageal adenocarcinoma patients. British Journal of Cancer. 113(6). 878–885. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francesca Simionato Breakdown of academic impact, for papers by Camilla Zecchetto Breakdown of academic impact, for papers by Guido Giordano Breakdown of academic impact, for papers by Lydie Crescence Breakdown of academic impact, for papers by Markus W. Buechler Breakdown of academic impact, for papers by Cinzia Puppin Breakdown of academic impact, for papers by Brett H. Herzog Breakdown of academic impact, for papers by Behrouz Zand Breakdown of academic impact, for papers by Moubin Lin Breakdown of academic impact, for papers by Sylvia Timme
Rankless by CCL
2026